PATENT CLAIM ANALYSIS

Application Number: 16178865
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "487000"]

Abstract:
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 18):
The dosage form of  claim 9 , wherein the membrane ruptures from 0.1 to 1.5 hours after exposure of said extended release dosage form to an aqueous environment of use.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 98.0
- Lexical Diversity: 1.47222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15673781', '15680434', '15048743', '15919422', '15919436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.842690652641154
- 35 USC 102 Novelty (BERT): 0.6137550764542176
- Combined Prediction Score: 0.8197970950224603
- Mean Citation Score: 562.2168720000002
- Max Citation Score: 573.3431
- Similarity Product: 480.93390350955735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test